Featured Research

from universities, journals, and other organizations

New compound could become important new antidepressant

Date:
February 7, 2010
Source:
Oregon State University
Summary:
Chemists have discovered and synthesized a new compound that in laboratory and animal tests appears to be similar to, but may have advantages over one of the most important antidepressant medications in the world.

Chemists at Oregon State University have discovered and synthesized a new compound that in laboratory and animal tests appears to be similar to, but may have advantages over one of the most important antidepressant medications in the world.

A patent has been applied for on the compound, and findings on it published in the Journal of Medicinal Chemistry. Continued animal studies and eventually, human clinical trials will be necessary before the compound could be approved for human medical use, researchers say.

"Based on our results so far, this promises to be one of the most effective antidepressants yet developed," said James White, a professor emeritus of chemistry at OSU. "It may have efficacy similar to some important drugs being used now, but with fewer side effects."

Early antidepressants such as tricyclic antidepressants, White said, often had undesirable effects such as constipation, dry mouth, drowsiness and hypotension, or low blood pressure. They worked by helping the body to raise levels of such neurotransmitter compounds as serotonin, norepinephrine, dopamine and others. A second generation of antidepressants, which included the drugs Prozac and Zoloft, were more selective and produced only minor side effects, but often took weeks to become effective and sometimes didn't help patients adequately.

"The prototype of the third-generation drug in this field is Cymbalta, which tries to better balance the inhibited re-uptake of serotonin and norepinephrine, further reducing side effects and offering more immediate efficacy," White said. "It's been extremely popular."

The new compound developed at OSU, however, has properties similar to Cymbalta in some ways, but in laboratory and animal studies does a better job at balancing body chemistry.

"Our compound is 10 times better than Cymbalta at inhibiting the re-uptake of norepinephine and comes close to the holy grail of a perfectly balanced antidepressant," White said. "It should produce even fewer side effects, such as concerns with constipation and hypotension. Final results, of course, won't be known until the completion of human clinical trials."

The OSU research has been supported by the National Institute of Alcoholism and Alcohol Abuse -- an agency interested in improved antidepressants, White said, because they are often used in treatment of alcoholism. The work has been done in collaboration with the University of Indiana.


Story Source:

The above story is based on materials provided by Oregon State University. Note: Materials may be edited for content and length.


Cite This Page:

Oregon State University. "New compound could become important new antidepressant." ScienceDaily. ScienceDaily, 7 February 2010. <www.sciencedaily.com/releases/2010/02/100204144821.htm>.
Oregon State University. (2010, February 7). New compound could become important new antidepressant. ScienceDaily. Retrieved July 29, 2014 from www.sciencedaily.com/releases/2010/02/100204144821.htm
Oregon State University. "New compound could become important new antidepressant." ScienceDaily. www.sciencedaily.com/releases/2010/02/100204144821.htm (accessed July 29, 2014).

Share This




More Health & Medicine News

Tuesday, July 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Deadly Ebola Virus Threatens West Africa

Deadly Ebola Virus Threatens West Africa

AP (July 28, 2014) West African nations and international health organizations are working to contain the largest Ebola outbreak in history. It's one of the deadliest diseases known to man, but the CDC says it's unlikely to spread in the U.S. (July 28) Video provided by AP
Powered by NewsLook.com
$15B Deal on Vets' Health Care Reached

$15B Deal on Vets' Health Care Reached

AP (July 28, 2014) A bipartisan deal to improve veterans health care would authorize at least $15 billion in emergency spending to fix a veterans program scandalized by long patient wait times and falsified records. (July 28) Video provided by AP
Powered by NewsLook.com
Two Americans Contract Ebola in Liberia

Two Americans Contract Ebola in Liberia

Reuters - US Online Video (July 28, 2014) Two American aid workers in Liberia test positive for Ebola while working to combat the deadliest outbreak of the virus ever. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Traditional African Dishes Teach Healthy Eating

Traditional African Dishes Teach Healthy Eating

AP (July 28, 2014) Classes are being offered nationwide to encourage African Americans to learn about cooking fresh foods based on traditional African cuisine. The program is trying to combat obesity, heart disease and other ailments often linked to diet. (July 28) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins